Nonoperating Income (Expense) of Vicapsys Life Sciences, Inc. from 31 Mar 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Vicapsys Life Sciences, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Mar 2021 to 30 Sep 2024.
  • Vicapsys Life Sciences, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2024 was $36,645, a 44% increase year-over-year.
  • Vicapsys Life Sciences, Inc. annual Nonoperating Income (Expense) for 2023 was $135,134.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)

Vicapsys Life Sciences, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $36,645 +$28,272 +44% 01 Jul 2024 30 Sep 2024 10-Q 10 Jan 2025 2024 Q3
Q2 2024 $8,250 01 Apr 2024 30 Jun 2024 10-Q 10 Jan 2025 2024 Q2
Q1 2024 $122,817 01 Jan 2024 31 Mar 2024 10-Q 10 Jan 2025 2024 Q1
Q3 2023 $64,917 01 Jul 2023 30 Sep 2023 10-Q 10 Jan 2025 2024 Q3
Q1 2021 $100,000 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1

Vicapsys Life Sciences, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $135,134 01 Jan 2023 31 Dec 2023 10-K 21 Oct 2024 2023 FY
2021 $100,000 01 Jan 2021 31 Dec 2021 10-K 14 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.